UNSPSC 85494216: Supplement aortic valve with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement aortic valve with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UF37Z

UNSPSC 85494216 Supplement aortic valve with autologous tissue substitute, percutaneous approach is a Commodity code with no recent state and local procurement activity aligned to cardiovascular implant devices. The six opportunities posted between July and September 2026 tagged to this code describe independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty care for youth in detention, pharmacy benefit management, and temporary health professional staffing — none of which involve aortic valve implants or cardiac surgical supplies. The code designation appears to be a mislabeling artifact in the state and local procurement system rather than a genuine category for device procurement at this tier.

State and local issuers soliciting healthcare services under this code include county governments (Collier County in Florida, Harris County in Texas, Santa Clara County in California), cities (Phoenix and Long Beach), and state transportation agencies (Washington State Department of Transportation). The geographic spread spans Florida, Texas, California, Arizona, and Washington, with no pattern of repeated activity under this specific commodity code. Absent current procurement activity aligned to cardiac implant devices, the code does not present a meaningful opportunity set for business development in state and local markets.